126 related articles for article (PubMed ID: 30013390)
1.
Yang P; Wang M; Tian T; Feng Y; Zheng Y; Yang T; Li H; Lin S; Xu P; Deng Y; Hao Q; Li N; Guan F; Dai Z
Cancer Manag Res; 2018; 10():1791-1798. PubMed ID: 30013390
[TBL] [Abstract][Full Text] [Related]
2. CYP17 polymorphism (rs743572) is associated with increased risk of gallbladder cancer in tobacco users.
Rai R; Sharma KL; Misra S; Kumar A; Mittal B
Tumour Biol; 2014 Jul; 35(7):6531-7. PubMed ID: 24687554
[TBL] [Abstract][Full Text] [Related]
3. Association between CYP17 T-34C rs743572 and breast cancer risk.
Sun J; Zhang H; Gao M; Tang Z; Guo D; Zhang X; Wang Z; Li R; Liu Y; Sun W; Sun X
Oncotarget; 2018 Jan; 9(3):4200-4213. PubMed ID: 29423115
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphism CYP17 rs2486758 and metabolic risk factors predict daily salivary 17β-estradiol concentration in healthy premenopausal Norwegian women. The EBBA-I study.
Iversen A; Thune I; McTiernan A; Makar KW; Wilsgaard T; Ellison PT; Jasienska G; Flote V; Poole EM; Furberg AS
J Clin Endocrinol Metab; 2012 May; 97(5):E852-7. PubMed ID: 22419734
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in CYP17 and endometrial cancer risk.
Gaudet MM; Lacey JV; Lissowska J; Peplonska B; Brinton LA; Chanock S; Garcia-Closas M
Hum Genet; 2008 Mar; 123(2):155-62. PubMed ID: 18172694
[TBL] [Abstract][Full Text] [Related]
6. CYP17 gene polymorphisms and prostate cancer risk: a meta-analysis based on 38 independent studies.
Wang F; Zou YF; Feng XL; Su H; Huang F
Prostate; 2011 Aug; 71(11):1167-77. PubMed ID: 21656827
[TBL] [Abstract][Full Text] [Related]
7. CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
Setiawan VW; Schumacher FR; Haiman CA; Stram DO; Albanes D; Altshuler D; Berglund G; Buring J; Calle EE; Clavel-Chapelon F; Cox DG; Gaziano JM; Hankinson SE; Hayes RB; Henderson BE; Hirschhorn J; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Ma J; Le Marchand L; Linseisen J; Lund E; Navarro C; Overvad K; Palli D; Peeters PH; Pike MC; Riboli E; Stampfer MJ; Thun MJ; Travis R; Trichopoulos D; Yeager M; Ziegler RG; Spencer Feigelson H; Chanock SJ
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2237-46. PubMed ID: 18006912
[TBL] [Abstract][Full Text] [Related]
8. CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study.
Antognelli C; Del Buono C; Ludovini V; Gori S; Talesa VN; Crinò L; Barberini F; Rulli A
BMC Cancer; 2009 Apr; 9():115. PubMed ID: 19379515
[TBL] [Abstract][Full Text] [Related]
9. Genetic Variation in Metastasis-Associated in Colon Cancer-1 and the Risk of Breast Cancer Among the Chinese Han Population: A STROBE-Compliant Observational Study.
Dai ZJ; Liu XH; Kang HF; Wang XJ; Jin TB; Zhang SQ; Feng T; Ma XB; Wang M; Feng YJ; Liu K; Xu P; Guan HT
Medicine (Baltimore); 2016 Feb; 95(6):e2801. PubMed ID: 26871844
[TBL] [Abstract][Full Text] [Related]
10. The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis.
Ye Z; Parry JM
Mutagenesis; 2002 Mar; 17(2):119-26. PubMed ID: 11880540
[TBL] [Abstract][Full Text] [Related]
11. Role of CYP17 rs743572 Polymorphism in Benign Prostatic Hyperplasia: A Multivariate Integrated Analysis.
Weng H; Fang C; Geng PL; Jin YH; Zeng XT; Wang XH
Front Physiol; 2019; 10():774. PubMed ID: 31293443
[No Abstract] [Full Text] [Related]
12. Genetic polymorphisms (rs10636 and rs28366003) in metallothionein 2A increase breast cancer risk in Chinese Han population.
Liu D; Wang M; Tian T; Wang XJ; Kang HF; Jin TB; Zhang SQ; Guan HT; Yang PT; Liu K; Liu XH; Xu P; Zheng Y; Dai ZJ
Aging (Albany NY); 2017 Feb; 9(2):547-555. PubMed ID: 28228606
[TBL] [Abstract][Full Text] [Related]
13.
Wang Y
Front Oncol; 2021; 11():657168. PubMed ID: 34178643
[TBL] [Abstract][Full Text] [Related]
14. HSD17B1 and CYP17 polymorphisms and breast cancer risk among Chinese women in Singapore.
Wu AH; Seow A; Arakawa K; Van Den Berg D; Lee HP; Yu MC
Int J Cancer; 2003 Apr; 104(4):450-7. PubMed ID: 12584742
[TBL] [Abstract][Full Text] [Related]
15. FEN1 gene variants confer reduced risk of breast cancer in chinese women: A case-control study.
Lin S; Wang M; Liu X; Lu Y; Gong Z; Guo Y; Yang P; Tian T; Dai C; Zheng Y; Xu P; Li S; Zhu Y; Dai Z
Oncotarget; 2016 Nov; 7(47):78110-78118. PubMed ID: 27801669
[TBL] [Abstract][Full Text] [Related]
16. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
17. Impacts of
Peng L; Huang C; Xing S; Li D; He C; He Y; Yang W; Jin T; Wang L
J Oncol; 2021; 2021():4990695. PubMed ID: 34475952
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of estrogen receptor genes are associated with breast cancer susceptibility in Chinese women.
Dai Z; Tian T; Wang M; Yang T; Li H; Lin S; Hao Q; Xu P; Deng Y; Zhou L; Li N; Diao Y
Cancer Cell Int; 2019; 19():11. PubMed ID: 30636932
[TBL] [Abstract][Full Text] [Related]
19. Association study of germline variants in CCNB1 and CDK1 with breast cancer susceptibility, progression, and survival among Chinese Han women.
Li Y; Chen YL; Xie YT; Zheng LY; Han JY; Wang H; Tian XX; Fang WG
PLoS One; 2013; 8(12):e84489. PubMed ID: 24386390
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms in caveolin-1 associate with breast cancer risk in Chinese Han population.
Wang M; Tian T; Ma X; Zhu W; Guo Y; Duan Z; Fan J; Lin S; Liu K; Zheng Y; Sheng Q; Dai ZJ; Peng H
Oncotarget; 2017 Oct; 8(53):91654-91661. PubMed ID: 29207674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
